Chemistry: analytical and immunological testing – Biological cellular material tested
Reexamination Certificate
2002-09-05
2008-12-30
Weber, Jon P (Department: 1657)
Chemistry: analytical and immunological testing
Biological cellular material tested
C436S086000, C435S015000, C435S017000
Reexamination Certificate
active
07470542
ABSTRACT:
The present invention relates to the use of naturally occurring compounds and derivatives thereof as markers for predisposition of diabetes related diseases. The invention also relates to a pharmaceutical composition for treatment of the diabetes related diseases.
REFERENCES:
patent: 5786150 (1998-07-01), Hillman et al.
patent: 6140067 (2000-10-01), Anderson et al.
patent: WO 98/17826 (1998-04-01), None
patent: WO 98/20124 (1998-05-01), None
patent: WO 99/36526 (1999-07-01), None
patent: WO-00/04037 (2000-01-01), None
patent: WO 00/66762 (2000-11-01), None
patent: WO 00/66782 (2000-11-01), None
patent: WO 01/34833 (2001-05-01), None
Capuano et al. Oxidative Phosphorylation and F0F1 ATP Synthase Activity of Human Hepatocellular Carcinoma; Biochemistry and Molecular Biology International, vol. 38, No. 5 (1996) pp. 1013-1022.
Mayfield, J. Diagnosis and Classification of Diabetes Mellitus: New Criteria; American Family Physician, vol. 58, No. 6 (1998).
Seffernick et al. Melamine Deaminase and Atrazine Chlorohydrolase: 98% Identical But Functionally Different; Journal of Bacteriology, vol. 183, No. 8 (2001) pp. 2405-2410.
Kelley, D.E. et al., “Fuel selection in human skeletal muscle in insulin resistance. A reexamination,” Diabetes 49, 677-683 (2000).
Gebhart, S. et al., “Insulin resistance associated with maternally inherited diabetes and deafness,” Metabolism. 45, 526-531 (1996).
Wallace, D.C., “Mitochrondrial diseases in man and mouse,” Science 283, 1482-1488 (1999).
Pandey, P. et al., “Proteomics to study genes and genomes,” Nature 405, 837-846 (2000).
Hickson, R.C. et al., “Skeletal muscle enzyme alterations after sprint and endurance training,” Appl. Physiol. 40, 868-871 (1976).
Lillioja, S. et al., “Skeletal muscle capillary density, and fiber type are possible determinants of in vivo resistance in man,” J. Gun. Invest. 80, 415-424 (1987).
Pearl, H.P. et al., “Structure and in vivo function of Hsp90,” Curr. Opin. Strct. Biol. 10, 46-51 (2000).
Nishizawa, J. et al., “Reactive oxygen species play an important role in the activation of heat shock factor 1 in ischemic-reperfused heart,” Circulation 99, 934-941 (2000).
Nishikawa, T. et al., “Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage,” Nautre 404, 787-790 (2000).
Sato, S. et al., “Modulation of Akt kinase activity by binding to Hsp90,” Proc. Natl. Acad. Sci. USA 97, 10832-10837 (2000).
Garcia-Cardena, G. et al., “Dynamic activation of endothelial nitric oxide synthase by Hsp90,” Nature 392, 821-824 (1998).
Fryer, L.G.D. et al., “Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase,” Diabetes 49, 1978-1985 (2000).
Poetter, K. et al., “Mutations in either essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle,” Nature Genetics 13, 63-69 (1996).
Apple, F. S., “Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB,” Clin. Chem. Acta. 284, 151-159 (1999).
Apple, F.S. et al., “CK and LD isoenzymes in human single muscle fibres in trained athletes,” J. Appl. Physiol. 66, 2717-2720 (1989).
Wallimann, T. et al., “Some new aspects of creatine Kinease (CK): compartmentation , structure, function and regulation for cellular and mitochondrial bioenergetics and physiology,” Biofactors 8, 299-234 (1998).
Winder, W.W. et al., “AMP-activated protein kinase, a metobolic master switch: possible roles in Type 2 diabetes,” Am. J. Physiol. Endocrinol. Metab. 277, E1-E10 (1999).
Boyer, P.D. “Catalytic site forms and controls in ATP synthase catalysis,” Biochim. Biophys. Acta. 1458, 252-262 (2000).
Groth, G. et al., “Characterization of a phosphate binding domain on the ∝-subunit of chloroplast ATP synthase using the photoaffinity phosphate analogue 4-azido-2-nitrophenyl phosphate,” Biochemistry 39, 13781-13787 (2000).
Wu, Z. et al., “Mechanism cntrolling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-I,” Cell 98, 115-124 (1999).
Gonzalez, B. et al., “Stress proteins of 70 kDa in chronically exercised skeletal muscle,” Pflugers Arch—Eur. J. Physiol. 440, 42-49 (2000).
Boss,O. et al., “Uncoupling proteins 2 and 3. Potential regulators of mitochondrial energy metabolism,” Diabetes 49, 143-156 (2000).
Shrauwen, P. et al., “The effect of weight reduction on skeletal muscle UCP2 and UCP3 mRNA expression and UCP3 protein content in Type II diabetic subjects,” Diabetologia 43, 1408-1416 (2000).
Bao, S. et al., “Expression of mRNAs encoding uncoupling proteins in human skeletal muscle. Effects of obesity and diabetes,” Diabetes 47, 1935-1940 (199*).
Hojlund, K. et al., “Reference intervals for glucose, n-cell polypeptides, and counterregulatory factors during prolonged fasting,” Am. J. Physiol. Endocrinol. Metab. 280, E50-E58 (2001).
Fey, S. J. et al., “Proteome analysis ofSaccharmomyces cerevisiae: a methodological outline,” Electrophoresis 8, 1361-1372 (1997).
Jensen, O. N. et al., “Mass spectrometric identification and microcharacterization of proteins from electrophoretic gels: strategies and applications,” Proteins 2 74-89 (1998).
Hemmer, W., Skarli, M. Perriard, J. C. & Wallimann, T. (19993) FEBS Letters 327, 35-40.
Manning, D. R. & Stull, S. (1982) Am. J. Physiol. 242, C234-241.
Menz, R.I., Walker, J.E. & Leslie, A. G. W. (2001) Cell 106, 331-341.
Vincent, D. et al., “Aleterations in skeletal muscle gene expression of obiob Mice by mRNA differential display,” Diabetes 47, 1451-1458 (Sep. 1998).
Kagawa, Y. et al., “Regulation of energy metabolism in human cells in aging and diabetes: F0f1, mtDNA, UCP, and ROS,” Biochemical and Biophysical Research Communications 266, 662-676 (1999).
Database EMBL [Online] created Nov. 26, 1990, “The human ATP synthase beta subunit gene: sequence analys assignment, and differential expression,”retrieved from EBI accession No. M27132, the whole document.
Beck-Nielsen, H., “Mechanisms of insulin resistance in non-oxidative glucose metabolism: The role of glycogen synthase,” J. Basic Clin. Physiol. Pharmacol. 9, 255-279 (1998), (Abstract only).
Beck-Nielsen Henning
Fey Stephen J.
Højlund Kurt
Larsen Peter Mose
Wrzesinski Krzysztof
Birch & Stewart Kolasch & Birch, LLP
Martin Paul C.
Pride Proteomics A/S
Weber Jon P
LandOfFree
Proteins in type 2 diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteins in type 2 diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteins in type 2 diabetes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4037180